Genetically modified mouse lines with a limited repertoire of the isoforms for leukemia-associated transcription factor, AML1/RUNX1.

被引：0
|
作者：
Nishimura, M
Fujita, Y
Nakao, M
Fukushima, Y
Toda, S
Kitamura, N
Abe, T
Okuda, T
机构：
[1] Kyoto Prefectural Univ Med, Dept Hyg, Kyoto 602, Japan
[2] Kyoto Prefectural Univ Med, Dept Thorac Surg, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Dept Internal Med 3, Kyoto 602, Japan
[4] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 602, Japan
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1182
引用
收藏
页码：280A / 281A
页数：2
相关论文
共 50 条
  • [31] The hematopoietic transcription factor Runx1 (AML1) is negatively regulated by the cell cycle protein cyclin D3.
    Peterson, LF
    Ranganathan, V
    Iwama, A
    Tsai, S
    Zhang, DE
    BLOOD, 2002, 100 (11) : 299A - 299A
  • [32] RUNX1/AML1 Mutants Collaborate with BMI1 in the Development of Myelodysplastic Syndromes (MDS)/Acute Myeloid Leukemia (AML) in a Mouse BMT Model.
    Harada, Hironori
    Inoue, Daichi
    Doki, Noriko
    Ding, Ye
    Harada, Yuka
    Kitamura, Toshio
    BLOOD, 2012, 120 (21)
  • [33] Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies
    McNeil, S
    Javed, A
    Harrington, KS
    Lian, JB
    Stein, JL
    van Wijnen, AJ
    Stein, GS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2000, 79 (01) : 103 - 112
  • [34] Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions
    Quentin, Samuel
    Cuccuini, Wendy
    Ceccaldi, Raphael
    Nibourel, Olivier
    Pondarre, Corinne
    Pages, Marie-Pierre
    Vasquez, Nadia
    d'Enghien, Catherine Dubois
    Larghero, Jerome
    de Latour, Regis Peffault
    Rocha, Vanderson
    Dalle, Jean-Hugues
    Schneider, Pascale
    Michallet, Mauricette
    Michel, Gerard
    Baruchel, Andre
    Sigaux, Francois
    Gluckman, Eliane
    Leblanc, Thierry
    Stoppa-Lyonnet, Dominique
    Preudhomme, Claude
    Socie, Gerard
    Soulier, Jean
    BLOOD, 2011, 117 (15) : E161 - E170
  • [35] The AML1/ETO(MTG8) and AML1/EVI-1 leukemia-associated chimeric oncoproteins accumulate PEBP2 beta(CBF beta) in the nucleus more efficiently than wild-type AML1.
    Tanaka, K
    Tanaka, T
    Kurokawa, M
    Imai, Y
    Ogawa, S
    Hiebert, SW
    Mitani, K
    Yazaki, Y
    Hirai, H
    BLOOD, 1996, 88 (10) : 2188 - 2188
  • [36] Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia
    Dicker, Frank
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    Schnittger, Susanne
    BLOOD, 2007, 110 (04) : 1308 - 1316
  • [37] The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications (vol 45, pg 129, 2003)
    Asou, Norio
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 (01) : 87 - 87
  • [38] The Leukemia-Associated Rho Guanine Nucleotide Exchange Factor (LARG) Is Essential for Survival and Proliferation of AML1-ETO Associated AML Cells
    Sheni, Shuhong
    Zheng, Yi
    Mulloy, James C.
    BLOOD, 2011, 118 (21) : 420 - 421
  • [39] Isoforms of the Ets transcription factor NERF/ELF-2 physically interact with AML1 and mediate opposing effects on AML1-mediated transcription of the B cell-specific blk gene
    Cho, JY
    Akbarali, Y
    Zerbini, LF
    Gu, XS
    Boltax, J
    Wang, YH
    Oettgen, P
    Zhang, DE
    Libermann, TA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) : 19512 - 19522
  • [40] A genome-modified mouse line with an insertion mutation at the AML1/Runx1 gene locus detected from a patient with myelodysplastic syndrome.
    Fukushime-Nakase, Y
    Nakao, M
    Horiike, S
    Nishimura, M
    Taniwaki, M
    Sugimoto, T
    Okuda, T
    BLOOD, 2005, 106 (11) : 458A - 458A
12345